Peng Zhang

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Gas Chromatography

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Cancer medicine

Journal of cellular and molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Fangfang Liu, Xuemei Zhang, Mengyao Lu, Chun Liu, Xiaodong Zhang, Qian Chu, Yuan Chen, Peng Zhang
The association of genomic alterations with PD-L1 expression in Chinese patients with EGFR/ALK wild-type lung adenocarcinoma and potential predictive value of Hippo pathway mutations to immunotherapy. Cancer medicine 13 (3) (2024)
Fangfang Liu, Xuemei Zhang, Mengyao Lu, Chun Liu, Xiaodong Zhang, Qian Chu, Yuan Chen, Peng Zhang
The association of genomic alterations with PD-L1 expression in Chinese patients with EGFR/ALK wild-type lung adenocarcinoma and potential predictive value of Hippo pathway mutations to immunotherapy. Cancer medicine 13 (3) (2024)
Fangfang Liu, Xuemei Zhang, Mengyao Lu, Chun Liu, Xiaodong Zhang, Qian Chu, Yuan Chen, Peng Zhang
The association of genomic alterations with PD-L1 expression in Chinese patients with EGFR/ALK wild-type lung adenocarcinoma and potential predictive value of Hippo pathway mutations to immunotherapy. Cancer medicine 13 (3) (2024)
Xuemei Zhang, Youzhi Zhang, Qiaoyun Zhang, Mengyao Lu, Yuan Chen, Xiao-Yu Zhang, Peng Zhang
Role of AT-rich interaction domain 1A in gastric cancer immunotherapy: Preclinical and clinical perspectives. Journal of cellular and molecular medicine (2023)